Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
BWI
3 min read
48

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

November 23, 2024
0

Reading Time: 2 minutes Sydney, Australia:   Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled “Vaccines – Global Clinical Trial Landscape (2024).”

Continue Reading
Puma Reimagines Modern Retail With Las Vegas Flagship Store Unveiling
BWI
5 min read
38

Puma Reimagines Modern Retail With Las Vegas Flagship Store Unveiling

November 23, 2024
0

Reading Time: 4 minutes Somerville, Mass., United States:   PUMA has officially opened the doors to its second North American flagship store in Las Vegas at the BLVD Las Vegas. The 25,000-square-foot retail space, which spans an impressive three stories, redefines what it means to be

Continue Reading
CSP
7 min read
50

DUG Foodtechs rights issue is registered – conversion of BTA into shares

November 23, 2024
0

Reading Time: 5 minutes 22 November, 2024, Lund, Sweden NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN

Continue Reading
CSP
2 min read
50

Jetpak Top Holding AB (publ) applies for delisting

November 22, 2024
0

Reading Time: 2 minutes On 19 June 2024, Notalp Logistik AB (“Notalp”) announced a voluntary public offer to acquire all shares in Jetpak Top Holding AB (publ) (“Jetpak”) for SEK 98 in cash per share (the “Offer”). On 6 September 2024, the price in the

Continue Reading
CSP
3 min read
46

Update on the Share Distribution of CANNORDIC Shares

November 22, 2024
0

Reading Time: 2 minutes New cut-off date allows additional time to finalize shareholder holdings and ensures accuracy in share distribution. CS MEDICA A/S (CSMED) announces that the share distribution of CANNORDIC shares has been extended. The distribution, originally planned for shareholders registered as of today,

Continue Reading
CSP
4 min read
45

BAT Says NO to underage sales

November 22, 2024
0

Reading Time: 3 minutes Paris, May 30th 2024  BAT France agrees with the World Health Organization : minors should not have access to or consume any nicotine products On the occasion of World No Tobacco Day 2024, BAT France reaffirms its position that minors should

Continue Reading
CSP
2 min read
42

Paratus Increases Full-Year 2024 Earnings Guidance and Provides Update on Operations in Mexico

November 22, 2024
0

Reading Time: 2 minutes Hamilton, Bermuda, November 22, 2024 – Paratus Energy Services Ltd. (ticker “PLSV”) (“Paratus” or the “Company”) announces an upward revision of its full-year 2024 EBITDA guidance and provides commentary on the Company’s rig operations in Mexico, operated through its wholly-owned subsidiary

Continue Reading
CSP
1 min read
45

Nordea Bank Abp: Repurchase of own shares on 22.11.2024

November 22, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares22.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 22.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
2 min read
48

STOREBRAND ASA: Share buyback program completed

November 22, 2024
0

Reading Time: 2 minutes Storebrand’s buyback program, announced on 24 April 2024, is now completed. The total number of shares purchased under the program was 9 785 494 at an average price of NOK 112.41 per share, for a total consideration of NOK 1.1 billion.

Continue Reading
CSP
5 min read
46

DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients

November 22, 2024
0

Reading Time: 3 minutes COPENHAGEN, Denmark, 22 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the third quarter (Q3) of 2024. The Q3-2024 report is

Continue Reading